Sanofi SA (SNY)

49.95
0.87 1.77
NYSE : Health Care
Prev Close 49.08
Open 50.09
Day Low/High 49.94 / 50.25
52 Wk Low/High 36.81 / 50.24
Volume 854.70K
Avg Volume 1.13M
Exchange NYSE
Shares Outstanding 2.50B
Market Cap 122.94B
EPS 1.80
P/E Ratio 26.40
Div & Yield 1.64 (3.30%)

Latest News

FDA Official Calls for Ending Codeine Use in Kids Cough Products

FDA Official Calls for Ending Codeine Use in Kids Cough Products

An FDA advisory panel recommends that warnings on cough syrups be extended from young children to everyone under 18.

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

A small portion of the population is prone to "ultra-metabolize" codeine at rates far in excess of the general population.

Sanofi Has Good Potential Upside

Sanofi Has Good Potential Upside

I would buy strength above $50 and $51 in Sanofi.

European Pharma Companies Slip on MS Pricing Probe

European Pharma Companies Slip on MS Pricing Probe

House Democrats start probe into MS drug prices

Mylan Finalizes $465 Million EpiPen Settlement With DoJ

Mylan Finalizes $465 Million EpiPen Settlement With DoJ

The dispute became the center of a drug price firestorm.

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.

Sanofi Is Selling a Ton of Vaccines So It Decided to Hike Its Profit Outlook

Sanofi Is Selling a Ton of Vaccines So It Decided to Hike Its Profit Outlook

Sanofi is starting to offset diabetes franchise losses

Sanofi Pasteur Ships First Of Its U.S. Influenza Vaccine Doses For 2017-2018 Season

Sanofi Pasteur Ships First Of Its U.S. Influenza Vaccine Doses For 2017-2018 Season

- Health care providers anticipating initial shipments by early August to kick off influenza immunization season -

Dow Scores Record Close as Retail Roars Higher, Walmart Rallies

Dow Scores Record Close as Retail Roars Higher, Walmart Rallies

Upbeat guidance from Target inspires retail rally.

Dow on Track for Record Close as Retail Roars Higher, Walmart Rallies

Dow on Track for Record Close as Retail Roars Higher, Walmart Rallies

Upbeat guidance from Target inspires retail rally.

Healthcare Stocks Sell Off, Retail Rallies on Upbeat Guidance From Target

Healthcare Stocks Sell Off, Retail Rallies on Upbeat Guidance From Target

Upbeat guidance from Target inspires retail rally.

Sanofi Steps Up M&A Activity With $650 Million Purchase of Protein Sciences

Sanofi Steps Up M&A Activity With $650 Million Purchase of Protein Sciences

Sanofi was also recently engaged in two other deals that it lost out on.

Alnylam And Sanofi Genzyme Report Positive Results From Ongoing Phase 2 Open-Label Extension Study With Investigational RNAi Therapeutic Fitusiran In Patients With Hemophilia A And B With Or Without Inhibitors

Alnylam And Sanofi Genzyme Report Positive Results From Ongoing Phase 2 Open-Label Extension Study With Investigational RNAi Therapeutic Fitusiran In Patients With Hemophilia A And B With Or Without Inhibitors

Alnylam Pharmaceuticals , Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company and Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today new positive results from the ongoing...

Stocks Lower as Tech Losses Escalate, Senate Delays Its Healthcare Plan

Stocks Lower as Tech Losses Escalate, Senate Delays Its Healthcare Plan

Tech, healthcare slide weighs on rest of markets.

Senate Punts Vote on Healthcare Bill, Wall Street Fares Poorly

Senate Punts Vote on Healthcare Bill, Wall Street Fares Poorly

Healthcare's slide weighs on rest of markets.

Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout

Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout

The stock has been on fire.

Looking for Some Positive Spin

Breadth and volume should've been better.

Tesaro Stock Jumps on Sanofi, Gilead Takeover Interest

Tesaro Stock Jumps on Sanofi, Gilead Takeover Interest

If one of the two were to successfully acquire the company, it would get access to Zejula, a PARP inhibitor approved to treat women with ovarian cancer.

New Analysis Shows Sanofi's Soliqua® 100/33 Lowered HbA1c By More Than 2 Percent In Patients With Screening Levels Greater Than 9 Percent

- All subgroups treated with Soliqua 100/33 achieved a mean HbA1c of below 7 percent after 30 weeks -

In Senior Adults Treated With Basal Insulin, Switching To Sanofi's Toujeo® Halved Hypoglycemia Risk

- New DELIVER 3 Real-World Toujeo® Observational Study Confirms Reduction of Hypoglycemia in Real-Life Setting -

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Biotech Movers: Shire Falls on Stem Cell Program Transfer; Calithera, Synergy Up on FDA Approvals

Plus more from the biotechnology world on Wednesday, June 7.

Sony Patent Infringement Claim Results in Investigation of FujiFilm Imports

Sony Patent Infringement Claim Results in Investigation of FujiFilm Imports

The magnetic tape cartridges in the company's products will be under review.

Symantec Fingers North Korea as Perpetrator Behind 'WannaCry' Ransomware Attacks

Symantec Fingers North Korea as Perpetrator Behind 'WannaCry' Ransomware Attacks

The cybersecurity firm deemed it 'highly likely' that a group of hackers working with North Korea was behind the attack.

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices

The legislation would also force companies to announce planned price hikes.

TheStreet Quant Rating: B (Buy)